Document is current
Any future updates will be listed below
-
Authors
Patrizio, Pasquale https://orcid.org/0000-0003-4796-7078
Darmon, Sarah
Barad, David H.
Gleicher, Norbert
-
Funding
Funding for this research was provided by:
The Center For Human Reproduction
Foundation for Reproductive Medicine
- License Information
-
More Information
Article History
Received: 5 April 2024
Accepted: 25 November 2024
First Online: 7 December 2024
Declarations
:
: NG and DHB are listed as co-owners of several already awarded US patents claiming benefits from androgen supplementation in women with infertility conditions and perimenopausal hypo-androgenism-induced sexual dysfunction. Other patents relate to the diagnostic and potential therapeutic benefits of AMH. NG is a shareholder in Fertility Nutraceuticals LLC. NG and DHB, together with other co-inventors, receive patent royalties from Fertility Nutraceuticals, LLC. NG and DHB also received research support, travel funding, and lecture fees over the last 3 years from several pharma companies, however, not in any way related to this manuscript. PP and SD have nothing to disclose.
: Neither the CHR nor the Foundation for Reproductive Medicine had a role in study design, collection of data, interpretation of data, writing of the manuscript, or decisions to submit the manuscript for publication.
